Physician profile
Robert Olson
NPI 1235102971
$473,177.35
in general payments reported to CMS, 2019-2025
15 companies · $951 in 2025
The $951 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $429K · 2021: $6,972 · 2022: $6,759 · 2023: $4,314 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2,125 · Food and Beverage: $1,858 · Travel and Lodging: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,125.17 |
| Food and Beverage | $1,857.73 |
| Travel and Lodging | $1,282.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $412,500.00 | 2020 | |
| Flower Orthopedics Coporation | $28,060.67 | 2019-2023 | |
| In2bones USA, LLC | $22,132.59 | 2019-2022 | |
| Maxx Health INC | $4,963.14 | 2021-2023 | Summa Ortho Optossol |
| Linvatec Corporation | $3,502.92 | 2023-2025 | Colink Plating System, Colink Sfx, Colink Neofuse |
| Ossio INC | $1,630.81 | 2023 | |
| Vertos Medical, INC. | $128.24 | 2022-2023 | Mild Device Kit |
| Depuy Synthes Sales INC. | $59.89 | 2019-2022 | |
| Radius Health, INC. | $58.67 | 2020-2022 | |
| Stryker Corporation | $28.84 | 2022 | |
| Peerless Surgical INC. | $27.48 | 2019 | |
| Celularity INC. | $24.00 | 2019 | |
| Arthrosurface Incorporated | $20.63 | 2020 | |
| Wright Medical Technology, INC. | $20.02 | 2020 | |
| Ermi LLC | $19.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$787,500.24 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.